REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Clinical House S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Commercial and Industrial Machinery and Equipment Rental and Leasing | Diagnostic Imaging Centers
Full name: Ips Clinical House S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ips Clinical House S.A.S. is a company based in Colombia, with its head office in Cucuta. It operates in the Ambulatory Health Care Services industry. The company was established on July 24, 2014. The latest financial highlights indicate a net sales revenue increase of 51.56% in 2023. Its’ total assets recorded a growth of 14.74%. The net profit margin of Ips Clinical House S.A.S. decreased by 1.2% in 2023.

Headquarters
Av 1E Nro. 11 - 152
Cucuta; Norte de Santander;

Contact Details: Purchase the Ips Clinical House S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ips Clinical House S.A.S. report to view the information.
Incorporation Date:
July 24, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Clinical House S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
51.56%
Total operating revenue
51.56%
Operating profit (EBIT)
137.04%
Net Profit (Loss) for the Period
18.63%
Total assets
14.74%
Total equity
337.91%
Operating Profit Margin (ROS)
3.65%
Net Profit Margin
-1.2%
Return on Equity (ROE)
-45.19%
Debt to Equity Ratio
2.4%
Quick Ratio
1.69%
Cash Ratio
0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?